Back
Intra-Cellular Therapies Stock Price Chart
7 Nuclear Stocks to Buy Before They Surge
Get your report FREE today!
Buy
57
ITCI
Intra-Cellular Therapies
Last Price:
$131.70
Seasonality Move:
14.29%
7 Day Trial
ALL ACCESS PASS
$
7
Meet the Founder That's Revolutionizing Smartphones
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.-
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and ITCI is experiencing buying pressure, which is a positive indicator for future bullish movement.
Intra-Cellular Therapies Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 131.5 | Buy |
| 20-day SMA: | 130.64 | Buy |
| 50-day SMA: | 126.18 | Buy |
| 200-day SMA: | 89.78 | Buy |
| 8-day EMA: | 131.46 | Buy |
| 20-day EMA: | 130.27 | Buy |
| 50-day EMA: | 122.65 | Buy |
| 200-day EMA: | 96.25 | Buy |
Intra-Cellular Therapies Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 2.06 | Buy |
| Relative Strength Index (14 RSI): | 85.25 | Buy |
| Chaikin Money Flow: | 559328 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (128.63 - 131.67) | Buy |
| Bollinger Bands (100): | (83.49 - 127.53) | Buy |
Intra-Cellular Therapies Technical Analysis
| Mar 11 | Mar 12 | Mar 13 | Mar 14 | Mar 17 | Mar 18 | Mar 19 | Mar 20 | Mar 21 | Mar 24 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Mar | ||||||||||
| 11 | 12 | 13 | 14 | 17 | 18 | 19 | 20 | 21 | 24 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Intra-Cellular Therapies Stock
Is Intra-Cellular Therapies Stock a Buy?
-
Intra-Cellular Therapies share price is 131.70 while ITCI 8-day simple moving average is 131.50, which is a Buy signal.
-
The stock price of ITCI is 131.70 while Intra-Cellular Therapies 20-day SMA is 130.64, which makes it a Buy.
-
Intra-Cellular Therapies 50-day simple moving average is 126.18 while ITCI share price is 131.70, making it a Buy technically.
-
ITCI stock price is 131.70 and Intra-Cellular Therapies 200-day simple moving average is 89.78, creating a Buy signal.
ITCI Technical Analysis vs Fundamental Analysis
Buy
57
Intra-Cellular Therapies (ITCI)
is a Buy
Is Intra-Cellular Therapies a Buy or a Sell?
-
Intra-Cellular Therapies stock is rated a BuyThe current Intra-Cellular Therapies [ITCI] share price is $131.70. The Score for ITCI is 57, which is 14% above its historic median score of 50, and infers lower risk than normal.
Intra-Cellular Therapies Stock Info
Market Cap:
14B
Price in USD:
131.70
Share Volume:
661K
Intra-Cellular Therapies 52-Week Range
52-Week High:
131.71
52-Week Low:
64.09
Buy
57
Intra-Cellular Therapies (ITCI)
is a Buy
Intra-Cellular Therapies Share Price Forecast
-
What is the Intra-Cellular Therapies stock price today?The Intra-Cellular Therapies stock price is 131.70 USD today.
-
Will ITCI stock go up or go down?Intra-Cellular Therapies> share price is forecast to RISE/FALL based on technical indicators
-
Is Intra-Cellular Therapies overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Intra-Cellular Therapies is not overvalued.
Is Intra-Cellular Therapies Stock a Buy?
-
Intra-Cellular Therapies share price is 131.70 while ITCI 8-day exponential moving average is 131.46, which is a Buy signal.
-
The stock price of ITCI is 131.70 while Intra-Cellular Therapies 20-day EMA is 130.27, which makes it a Buy.
-
Intra-Cellular Therapies 50-day exponential moving average is 122.65 while ITCI share price is 131.70, making it a Buy technically.
-
ITCI stock price is 131.70 and Intra-Cellular Therapies 200-day simple moving average is 96.25, creating a Buy signal.
Fundamental Analysis of Intra-Cellular Therapies
Is Intra-Cellular Therapies a good investment?
-
Analysts estimate an earnings increase this quarter of $0.22 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.83 per share, and an increase next year of $3.58 per share.
Technical Analysis of Intra-Cellular Therapies
Should I short Intra-Cellular Therapies stock?
-
ITCI Moving Average Covergence Divergence (MACD) indicator is 2.06, suggesting Intra-Cellular Therapies is a Buy
-
Intra-Cellular Therapies Relative Strength Index (RSI) is 85.25, which suggest Intra-Cellular Therapies is overbought
-
The Bollinger Bands (25) for Intra-Cellular Therapies is (128.63 - 131.67), which suggest Intra-Cellular Therapies is a Buy
-
The Bollinger Bands (100) for Intra-Cellular Therapies is (83.49 - 127.53), which suggest Intra-Cellular Therapies is a Buy
* Intra-Cellular Therapies stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.